Professional Documents
Culture Documents
Jurnal Disminore
Jurnal Disminore
net/publication/6903136
Effect o f A r o m a t h e r a p y o n S y m p t o m s o f D y s m e n o r r h e a in C o l l e g e St udents: A
R a n d o m i z e d P l a c e b o - C o n t r o l l e d C l i ni c a l Trial
Article in Journal of alternative and complementary medicine (New York, N.Y.) · July 2006
DOI: 10.1089/acm.2006.12.535 · Source: PubMed
CITATIONS READS
115 3,797
5 authors, including:
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Myeong Soo Lee on 11 June 2015.
SUN-HEE HAN, Ph.D., R.N.,1 MYUNG-HAENG HUR, Ph.D., R.N.,2 JANE BUCKLE, Ph.D., R.N,3
JEEYAE CHOI, D.N.Sc., R.N.,4 and MYEONG SOO LEE, Ph.D.5
ABSTRACT
Objective: The purpose of this study was to explore the effect of aromatherapy on menstrual cramps and
symptoms of dysmenorrhea.
Design: The study was a randomized placebo-controlled trial.
Subjects: The subjects were 67 female college students who rated their menstrual cramps to be greater than
6 on a 10-point visual analogue scale, who had no systemic or reproductive diseases, and who did not use con-
traceptive drugs.
Intervention: Subjects were randomized into three groups: (1) an experimental group (n ϭ 25) who received
aromatherapy, (2) a placebo group (n ϭ 20), and (3) a control group (n ϭ 22). Aromatherapy was applied top-
ically to the experimental group in the form of an abdominal massage using two drops of lavender (Lavandula
officinalis), one drop of clary sage (Salvia sclarea), and one drop of rose (Rosa centifolia) in 5 cc of almond
oil. The placebo group received the same treatment but with almond oil only, and the control group received
no treatment.
Outcome measures: The menstrual cramps levels was assessed using a visual analogue scale and severity
of dysmenorrhea was measured with a verbal multidimensional scoring system.
Results: The menstrual cramps were significantly lowered in the aromatherapy group than in the other two
groups at both post-test time points (first and second day of menstruation after treatment). From the multiple
regression aromatherapy was found to be associated with the changes in menstrual cramp levels (first day:
Beta ϭ Ϫ2.48, 95% CI: Ϫ3.68 to Ϫ1.29, p Ͻ 0.001; second day: Beta ϭ Ϫ1.97, 95% CI: Ϫ3.66 to Ϫ0.29,
p ϭ 0.02 and the severity of dysmenorrhea (first day: Beta ϭ 0.31, 95% CI: 0.05 to 0.57, p ϭ 0.02; second day:
Beta ϭ 0.33, 95% CI: 0.10 to 0.56, p ϭ 0.006) than that found in the other two groups.
Conclusions: These findings suggest that aromatherapy using topically applied lavender, clary sage, and rose
is effective in decreasing the severity of menstrual cramps. Aromatherapy can be offered as part of the nurs-
ing care to women experiencing menstrual cramps or dysmenorrhea.
535
536 HAN ET AL.
was 55.3 Ϯ 3.8 mmHg in the relaxation phase and 175.0 Ϯ However, the therapeutic effects of aromatherapy are not
6.1 mmHg in the contraction phase, and that the IUP dur- well supported by clinical studies.19 Keville and Green20
ing contraction is greater than in labor.1 sug- gested that essential oils should be used for several
Dysmenorrhea is usually treated with drugs, such as anal- days be- fore dysmenorrhea or menstrual cramps are
gesics, sedatives, antispasmodics, prostaglandin inhibitors, expected. They recommend that the essential oils of
uterine contraction inhibitors, nonsteroidal anti-inflammatory chamomile (Chamomelum nobile), clary sage (Salvia
drugs, vasopressin antagonists, and medication to stop ovu- sclarea), lavender (Lavandula an- gustifolia), marjoram
lation.3 In a review article, Dawood3 suggested that none of (Origanum majorana), melissa (Melissa officinalis), and
these therapies are particularly effective but some may lead geranium (Pelargonium graveolens) help in treating
to dependence or affect cognitive function. Bed rest, local heat menstrual cramps. Tisserand15 suggested clary sage,
therapy, surgical intervention, and psychotherapy have also lavender, rose (Rosa centifolia), marjoram, geranium, and gin-
been used.3 In a 1999 survey, Han and Hur1 found that the ger (Rhizoma zingiberis recens) as effective in treating dys-
most common methods to cope with menstrual cramps were menorrhea. Dye13 suggested clary sage, chamomile, geranium,
“endurance” and medication. Campbell and McGrath4 found and rose, while Baker21 suggested geranium, Roman
that 70% of women with dysmenorrhea use medication. How- chamomile, rosemary, lavender, clary sage, and sage.
ever, Chambers et al.5 noted that the medication might not The essential oil of lavender is thought to be an adreno-
be effective if not used regularly. Many studies suggest that cortical stimulant that stimulates menstruation and circula-
men- strual cramps and dysmenorrhea are not managed tion and has anticonvulsive properties. Lavabre14 suggested
efficiently despite their high occurrence and severity. that lavender is also useful as a sedative and to alleviate
A variety of alternative methods have been used to treat pain. Tisserand 15 suggested that clary sage has functions
menstrual cramps. Some experimental studies have found similar to estrogen, such as normalizing the menstrual cy-
alternative methods such as acupuncture6 and transcuta- cle, promoting menstruation, and strengthening the uterus.
neous electrical nerve stimulation (TENS)7 to be fairly ef- Tisserand 15 also suggested that rose has a great affinity for
fective (e.g., 50% reduction in pain). Kotani et al.8 found the uterus and helps regulate the menstrual cycle and reduce
that the herbal medicine Toki-shakuyaku-san [Japanese an- excessive bleeding. In this study, we hypothesized that ap-
gelica root (Angelicae radix), peony root (Paeoniae radix), plying these three essential oils together would provide a
Poria (Hoelen spp.), Chinese atractylodes rhizome (Atracty- synergistic blend that would have the highest chance of suc-
lodis lanceae rhizoma), Oriental water plantian rhizome cess in treating the pain of menstrual cramps.
(Alismatis rhizome), Cnidium (cnidii rhizoma)] was more Different methods are used to deliver aromatherapy, such
ef- fective than placebo in treating primary dysmenorrhea. as diffusers, baths, massage, and compresses. Massage is
At- tempting to cure idiopathic menstrual pain, Kim* be- lieved to be an effective way to improve blood and
used a placebo in the form of a vitamin pill. Dawood and lymph circulation and to reduce stress and ease stiff
Ramos9 suggested that concurrent use of TENS and muscles. For massage, the essential oil is diluted in a cold-
ibuprofen might be an effective treatment, and Harel et pressed veg- etable oil, a popular choice being sweet
al.10 used supple- ments such as omega-3 fatty acids. almond oil. 13,14,20 Massage appears to be a suitable
TENS and ibuprofen to- method to deliver aro- matherapy to treat menstrual
cramps of dysmenorrhea.
*Kim G. The Effect of Menstrual Pain Relief by Placebo [un- The purpose of this study was to investigate whether the
published Master’s thesis]. Pusan, Korea; Department of Nursing, combination of lavender, clary sage, and rose applied topically
Pusan National University, 1985. alleviates menstrual cramps. If the results were positive, this
AROMATHERAPY MASSAGE EFFECT ON SYMPTOMS OF DYSMENORRHEA 537
method of aromatherapy might be adopted as a nursing sham aromatherapy, as were the clinical observers assess-
inter- vention for patients with painful menstrual cramps. ing the endpoints. Four assistants contacted the subjects and
checked their responses.
that is painful but seldom inhibits the woman’s normal ac- with respect to baseline. In each of these analyses, the
tivity and analgesics are seldom needed. Moderate dys- change score (postintervention minus preintervention) was
menorrhea affects daily activities and requires analgesics, regressed on the baseline score with two dummy-variable
but missing work or school is unusual. Severe dysmenor- indicators: one indicator was 1 for the placebo group and 0
rhea clearly inhibits daily activity, is managed poorly by otherwise, and the other was 1 for the aromatherapy group
analgesics, and has associated somatic symptoms such as and 0 other- wise. The coefficients of these indicators
headache, tiredness, nausea, vomiting, or diarrhea. Symp- therefore represent placebo versus control and aromatherapy
toms were scored from 1 to 4 (1 none; 2 mild; 3 moder- versus control com- parisons. This procedure was
ate; 4 severe), according to the intensity experienced by performed separately for the first- and second-day data.
the subjects. The severity of dysmenorrhea in each woman was di-
chotomized into either 1, representing improvement (mean-
Data analysis ing a strictly better postintervention score), or 0, represent-
ing no change or a lower postintervention score than
The data were analyzed using SigmaStat (Systat Software, preintervention score. We then applied generalized multiple
Richmond, CA) and SPSS software (SPSS, Chicago, IL). linear regression modeling to this outcome.
Since the data were not normally distributed, the results are
presented as medians and interquartile ranges (IQRs). All out-
comes were compared using the nonparametric Mann-Whit-
ney rank test between groups and the Wilcoxon signed-rank RESULTS
test across treatment times for each group.
Multiple regression analyses were used to estimate the The participants reported no side effects from the treat-
ef- fects and the validity of the hypothesis. We divided the ment. The demographic characteristics of the participants
analy- ses into two parts, analyzing the first- and second-day are listed in Table 1.
results
Time Change
Group Preintervention First day Second day First day—pre Second day—pre
Aromatherapy 7.0 (6.5–8.3) 5.0 (3.0–6.0)**,†‡ 3.0 (1.0–5.0)**,†‡ Ϫ2.5 (Ϫ5.0—Ϫ1.5) Ϫ4.5 (Ϫ5.0—Ϫ2.0)
Placebo 7.0 (6.0–8.0) 7.0 (6.0–8.0) 7.0 (2.8–8.0)* 0.0 (0.0—1.0) Ϫ0.5 (Ϫ5.0—1.0)
No treatment 7.5 (6.5–8.0) 7.0 (6.0–8.0) 7.0 (5.0–8.0) 0.0 (Ϫ1.0—0.3) 0.0 (Ϫ3.0—0.0)
Table 2 lists the medians and IQRs for the levels of men- and not for placebo (Beta ϭ Ϫ0.15, 95% CI: Ϫ0.40 to 0.10,
strual cramps in the groups measured at three time points. The p ϭ 0.23) compared to controls.
severity was significantly lower in the aromatherapy group
than in the other two groups at both postintervention time
points (first and second days of menstruation after treatment). DISCUSSION
Regression analyses were also applied to the changes in
severity at each day (postintervention minus One of the main goals of nursing is to enhance a patient’s
preintervention) using the baseline value, two indicators for quality of life, which might include providing proper
aromatherapy, and placebo compared to control. nursing care for patients with menstrual cramps or
Aromatherapy was most strongly associated with change in dysmenorrhea. Be- cause menstrual cramps and
severity (Beta ϭ Ϫ2.48, 95% CI: Ϫ3.68 to Ϫ1.29, p Ͻ dysmenorrhea are personal top- ics, women may suffer
0.001), followed by the baseline value of level of menstrual from these symptoms without seek- ing help from a
cramps (Beta ϭ Ϫ0.62, 95% CI: Ϫ0.99 to – 0.26, P ϭ 0.001), health care professional.4,24,25 In some extreme cases, the
with the weakest association being with placebo (Beta ϭ internal pressure from the uterine contrac- tion during
0.42, 95% CI: Ϫ0.83 to 1.67, p ϭ 0.51) com- pared to menstruation may be higher than that of labor.22 The
control for the first day. The trend was the same for the participants reported a serious level of discomfort before the
second day. Aromatherapy was most strongly associated experimental treatment, as shown by the mean rating of
with change in severity (Beta ϭ Ϫ1.97, 95% CI: Ϫ3.66 to menstrual cramps of 7.18 Ϯ 1.37 on the 10-point VAS.
Ϫ0.29, p ϭ 0.02), the baseline value of level of menstrual According to Sundell et al.23 and Han and Hur,1 greater
cramps (Beta ϭ Ϫ0.52, 95% CI: – 1.04 to – 0.003, p ϭ 0.05), menstrual flow is associated with more severe pain. The
and placebo (with the weakest association being with placebo pretest data showed no differences in menstrual flow be-
(Beta ϭ 0.27, 95% CI: Ϫ1.49 to 2.04, p ϭ 0.76) compared to tween the three groups. Han and Hur1 showed that variables
the control group). such as age at menarche and the interval and duration of
Table 3 lists the severity of dysmenorrhea. We estimated menstruation are not related to menstrual cramps. These
and tested the trends by applying multiple linear regression variables did not differ significantly between groups and the
modeling to the dichotomized severity of dysmenorrhea and age at menarche differed by only 0.3 of a year.
the dummy-variable indicators. The results demonstrated In the experimental group, the abdominal massage was
that aromatherapy was associated with the change in sever- given using 3% essential oils consisting of lavender, clary
ity (Beta ϭ 0.31, 95% CI: 0.05 to 0.57, p ϭ 0.02), the base- sage, and rose (2:1:1 ratio) diluted in almond oil. Massage
line value of severity (Beta ϭ 0.21, 95% CI: 0.04 to 0.37, is thought to enhance essential oil penetration into the skin.
p ϭ 0.02), and not for placebo (Beta ϭ Ϫ0.003, 95% CI: The VAS was used to measure the effect of the experi-
–0.29 to 0.28, p ϭ 0.98) compared to controls for the first mental treatment on menstrual cramps. Our results showed
day. The trend was the same for the second day. Aro- that the levels of the menstrual cramps were reduced in the
matherapy was associated with the severity change (Beta ϭ experimental group more significantly compared with those
0.33, 95% CI: 0.10 to 0.56, p ϭ 0.006), the baseline value of other groups. In the experimental group, the menstrual
of severity (Beta ϭ 0.33, 95% CI: 0.18 to 0.48, p Ͻ 0.001), cramps on the first menstruation day decreased from 7.40
21. Baker S. Menstruation and related problems and concern. In: 27. Akerlund M. Modern treatment of dysmenorrhea. Acta Obstet
Youngkin EQ, Davis MS, eds. Women’s Health, A Primary Gynecol Scand 1990;69:563–564.
Care Clinical Guide. Stamford, CT: Appleton & Lange, 1997, 28. Buckle J. Clinical Aromatherapy in Nursing. London: Arnold,
pp. 139–160. 1997.
22. Andersch B, Milsom I. An epidemiologic study of young
women with dysmenorrhea. Am J Obstet Gynecol 1982;144:
655–660.
23. Sundell G, Milsom I, Andersch B. Factors influencing the
Address reprint requests to:
prevalence and severity of dysmenorrhoea in young women. Myung-Haeng Hur, Ph.D., R.N.
Br J Obstet Gynaecol 1990;97:588–594. School of Nursing
24. Griffith-Kennedy J. Contemporary Women’s Health. A Nurs- Eulji University
ing Advocacy Approach. Menlo Park, CA: Addison-Wesley 143-5 Yongdudong, Jung-gu
Publishing, 1986. Daejeon, 302-832
25. Rees M. Dysmenorrhoea. Br J Obstet Gynaecol 1988;95: South Korea
833–835.
26. Akerlund M. Can primary dysmenorrhea be alleviated by a va- E-mail: mhhur@eulji.ac.kr
sopressin antagonist? Results of a pilot study. Acta Obstet Gy- Or:
necol Scand 1987;66:459–461. daeheelee@hanafos.com